NCT00221416View on ClinicalTrials.gov

An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Bipolar Disorder
Interventions
DRUG

Aripiprazole

5-20 mg/day

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Cincinnati

OTHER

NCT00221416 - An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder | Biotech Hunter | Biotech Hunter